Release Date: 30/09/16 11:36 Summary: Audited Statutory Financial Statements 30th June 2016-APG.AX Price Sensitive: No Download Document 2.36MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%